Earnings History Data for Mersana Therapeutics, Inc. (MRSN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Mersana Therapeutics, Inc.

Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
13-11-2024	PM		MRSN	Mersana Therapeutics, Inc.	310.37	-0.09	-0.18	-0.35	Mersana Therapeutics GAAP EPS of -$0.09 beats by $0.08, revenue of $12.6M beats by $5.04M [11/13/2024 7:12 AM]	2.62	0.42 (19.32%)	2.57	0.37 (16.82%)	1.15 - 6.28	2,014,113	1,470,000	46,806
Mersana Therapeutics Q3 2024 Earnings Preview [11/12/2024 10:45 AM] Mersana Therapeutics GAAP EPS of -$0.09 beats by $0.08, revenue of $12.6M beats by $5.04M [11/13/2024 7:12 AM] Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results [2024-11-13 07:00AM]
13-08-2024	PM		MRSN	Mersana Therapeutics	179.00	-0.20	-0.18	0.00	Mersana Therapeutics GAAP EPS of -$0.20 misses by $0.03, revenue of $2.3M misses by $6.42M [8/13/2024 7:05 AM]	1.36	-0.06 (-4.23%)	1.39	-0.03 (-2.11%)	1.07 - 6.28	1,501,874	1,030,000	1,617
Mersana Therapeutics Q2 2024 Earnings Preview [8/12/2024 1:48 PM] Mersana Therapeutics GAAP EPS of -$0.20 misses by $0.03, revenue of $2.3M misses by $6.42M [8/13/2024 7:05 AM]
09-05-2024	PM		MRSN	Mersana Therapeutics, Inc.	427.59	-0.16	-0.18	-0.52	Mersana Therapeutics GAAP EPS of -$0.16 beats by $0.02, revenue of $9.25M beats by $0.75M [5/9/2024 7:21 AM]	2.46	-0.94 (-27.65%)	3.49	0.09 (2.65%)	0.80 - 9.62	3,318,209	1,240,000	3,526
Mersana Therapeutics GAAP EPS of -$0.16 beats by $0.02, revenue of $9.25M beats by $0.75M [5/9/2024 7:21 AM] Mersana Therapeutics Q1 2024 Earnings Preview [5/8/2024 11:45 AM]
28-02-2024	PM		MRSN	Mersana Therapeutics	458.00	-0.16	-0.20	0.00	Mersana Therapeutics GAAP EPS of -$0.16 in-line, revenue of $10.7M misses by $4.07M [2/28/2024 7:21 AM]	4.84	0.58 (13.47%)	4.13	-0.14 (-3.28%)	0.80 - 9.62	3,041,642	2,040,000	10,961
Mersana Therapeutics Q4 2023 Earnings Preview [2/27/2024 1:35 PM] Mersana Therapeutics GAAP EPS of -$0.16 in-line, revenue of $10.7M misses by $4.07M [2/28/2024 7:21 AM]
07-11-2023	PM		MRSN	Mersana Therapeutics, Inc.	171.12	-0.35	-0.31	-0.61	Mersana Therapeutics GAAP EPS of -$0.35 beats by $0.02, revenue of $7.7M misses by $0.98M [11/7/2023 7:29 AM]	1.35	-0.03 (-2.52%)	1.39	0.0 (0.00%)	0.80 - 9.62	1,019,097	2,380,000	16,684
Mersana Therapeutics Q3 2023 Earnings Preview [11/6/2023 1:09 PM] Mersana Therapeutics GAAP EPS of -$0.35 beats by $0.02, revenue of $7.7M misses by $0.98M [11/7/2023 7:29 AM]
08-08-2023	PM		MRSN	Mersana Therapeutics	142.00	-0.47	-0.39	0.00	Mersana Therapeutics GAAP EPS of -$0.47, revenue of $10.65M [8/8/2023 9:56 AM]	1.23	0.03 (2.08%)	1.16	-0.04 (-3.29%)	0.80 - 9.62	2,485,661	30,010,000	101,467
Mersana Therapeutics GAAP EPS of -$0.47, revenue of $10.65M [8/8/2023 9:56 AM]
09-05-2023	PM	7:00 AM ET (May 9)	MRSN	Mersana Therapeutics, Inc.	775.63	-0.52	-0.41	-0.59	Mersana Therapeutics GAAP EPS of -$0.52 misses by $0.09, revenue of $7.8M misses by $10.49M [5/9/2023 7:20 AM]	7.98	0.56 (7.55%)	7.19	-0.23 (-3.10%)	2.68 - 8.34	2,026,110	3,600,000	6,206
Mersana Therapeutics Q1 2023 Earnings Preview [5/8/2023 1:14 PM] Mersana Therapeutics GAAP EPS of -$0.52 misses by $0.09, revenue of $7.8M misses by $10.49M [5/9/2023 7:20 AM]
28-02-2023	PM	7:00 AM ET (Feb 28)	MRSN	Mersana Therapeutics, Inc.	579.69	-0.44	-0.47	-0.68	Mersana Therapeutics GAAP EPS of -$0.44 beats by $0.05, revenue of $14.69M beats by $1.02M [2/28/2023 7:06 AM]	6.05	0.62 (11.42%)	0.0	0.0 (0.00%)	2.68 - 8.34	1,003,552	1,260,000	0
Mersana Therapeutics Q4 2022 Earnings Preview [2/27/2023 1:10 PM] Mersana Therapeutics GAAP EPS of -$0.44 beats by $0.05, revenue of $14.69M beats by $1.02M [2/28/2023 7:06 AM]
07-11-2022	PM	7:00 AM ET (Nov 7)	MRSN	Mersana Therapeutics, Inc.	741.40	-0.61	-0.03	-0.63	Mersana Therapeutics GAAP EPS of -$0.61 misses by $0.60, revenue of $5.57M misses by $51.21M [11/7/2022 7:15 AM]	6.64	-0.89 (-11.87%)	7.09	-0.45 (-5.97%)	2.68 - 10.01	1,000,002	880,000	2,066
Mersana Therapeutics GAAP EPS of -$0.61 misses by $0.60, revenue of $5.57M misses by $51.21M [11/7/2022 7:15 AM] Mersana Therapeutics Provides Business Update and Announces Third Quarter 2022 Financial Results [Nov-07-22 07:00AM] Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Nov-04-22 04:05PM]
08-08-2022	AH	4:00 PM ET (Aug 8)	MRSN	Mersana Therapeutics, Inc.	528.60	-0.55	-0.50	-0.59	Mersana Therapeutics GAAP EPS of -$0.55 misses by $0.03, revenue of $4.28M beats by $2.08M [8/8/2022 4:10 PM]	6.99	1.74 (33.14%)	6.26	1.01 (19.24%)	2.68 - 14.80	15,591,906	1,210,000	56,936
Mersana Therapeutics GAAP EPS of -$0.55 misses by $0.03, revenue of $4.28M beats by $2.08M [8/8/2022 4:10 PM] Mersana Therapeutics Provides Business Update and Announces Second Quarter 2022 Financial Results [Aug-08-22 04:04PM] Mersana Therapeutics Announces Option Agreement with GSK for the Co-Development and Commercialization of XMT-2056, an Immunosynthen ADC Targeting HER2 [Aug-08-22 04:02PM]
09-05-2022	PM	6:00 AM ET (May 9)	MRSN	Mersana Therapeutics, Inc.	356.15	-0.59	-0.31	-0.50	Mersana Therapeutics GAAP EPS of -$0.59 misses by $0.27, revenue of $2.03M [5/9/2022 7:08 AM]	3.19	-0.48 (-13.08%)	3.67	0.0 (0.00%)	3.13 - 15.41	1,173,004	830,000	150,905
Mersana Therapeutics GAAP EPS of -$0.59 misses by $0.27, revenue of $2.03M [5/9/2022 7:08 AM] Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [May-06-22 04:05PM] Mersana Therapeutics Provides Business Update and Announces First Quarter 2022 Financial Results [May-09-22 07:00AM] Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Lags Revenue Estimates [May-09-22 08:25AM]
28-02-2022	PM	6:00 AM ET (Feb 28)	MRSN	Mersana Therapeutics, Inc.	283.33	-0.68	-0.67	-0.42	Mersana Therapeutics GAAP EPS of -$0.68 misses by $0.01, revenue of $0.01M in-line [2/28/2022 6:09 AM]	4.38	0.30 (7.21%)	4.01	-0.08 (-1.96%)	3.51 - 20.28	830,739	1,860,000	4,400
Mersana Therapeutics GAAP EPS of -$0.68 misses by $0.01, [2/28/2022 6:10 AM] Mersana Therapeutics GAAP EPS of -$0.68 misses by $0.01, revenue of $0.01M in-line [2/28/2022 6:09 AM] Mersana Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update [Feb-28-22 06:00AM] Mersana Therapeutics, Inc. (MRSN) Reports Q4 Loss, Tops Revenue Estimates [Feb-28-22 07:15AM]
09-11-2021	PM	6:00 AM ET (Nov 9)	MRSN	Mersana Therapeutics, Inc.	696.80	-0.63	-0.58	-0.33	Mersana Therapeutics EPS misses by $0.05, beats on revenue [11/9/2021 6:03 AM]	9.56	-0.05 (-0.52%)	9.61	0.0 (0.00%)	8.03 - 29.09	299,591	550,000	3,956
Mersana Therapeutics EPS misses by $0.05, beats on revenue [11/9/2021 6:03 AM] Mersana Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update [Nov-09-21 06:00AM] Mersana Therapeutics, Inc. (MRSN) Reports Q3 Loss, Tops Revenue Estimates [Nov-09-21 07:15AM]
06-08-2021	PM	6:00 AM ET (Aug 6)	MRSN	Mersana Therapeutics, Inc.	758.92	-0.59	-0.50	-0.33	Mersana Therapeutics EPS misses by $0.09 [8/6/2021 6:04 AM]	12.32	0.20 (1.65%)	12.12	0.0 (0.00%)	10.34 - 29.09	918,790	830,000	10,447
Mersana Therapeutics EPS misses by $0.09 [8/6/2021 6:04 AM] Mersana Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update [Aug-06-21 06:00AM]
10-05-2021	AH	4:20 PM ET (May 10)	MRSN	Mersana Therapeutics, Inc.	1,030	-0.50	-0.39	-0.35	Mersana Therapeutics EPS misses by $0.11, misses on revenue [5/10/2021 4:14 PM]	14.60	-0.32 (-2.14%)	14.92	0.0 (0.00%)	9.00 - 29.09	797,002	570,000	17,419
Mersana Therapeutics EPS misses by $0.11, misses on revenue [5/10/2021 4:14 PM] Mersana Therapeutics, Inc. to Host Earnings Call [May-10-21 02:30PM] Mersana Therapeutics Announces First Quarter 2021 Financial Results and Provides Business Update [May-10-21 04:01PM] Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Lags Revenue Estimates [May-10-21 05:45PM]
26-02-2021	PM	6:00 AM ET (Feb 26)	MRSN	Mersana Therapeutics, Inc.	1,300	-0.42	-0.33	-0.34	Mersana Therapeutics EPS misses by $0.10, misses on revenue [2/26/2021 6:04 AM]	18.20	-0.17 (-0.93%)	18.19	-0.18 (-0.98%)	4.12 - 29.09	724,574	817,031	110
Mersana Therapeutics EPS misses by $0.10, misses on revenue [2/26/2021 6:04 AM] Mersana Therapeutics, Inc. (MRSN) Reports Q4 Loss, Lags Revenue Estimates [Feb-26-21 07:30AM] Mersana Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update [Feb-26-21 06:00AM]
09-11-2020	PM	6:00 AM ET (Nov 9)	MRSN	Mersana Therapeutics, Inc.	1,600	-0.33	-0.31	-0.35	Mersana Therapeutics EPS misses by $0.02 [11/9/2020 6:05 AM]	22.96	0.58 (2.59%)	21.71	-0.67 (-2.99%)	2.06 - 26.64	924,824	704,613	183

07-08-2020	PM	6:00 AM ET (Aug 7)	MRSN	Mersana Therapeutics, Inc.	1,390	-0.33	-0.30	-0.36	Mersana Therapeutics EPS misses by $0.03, beats on revenue [8/7/2020 6:01 AM]	20.08	-0.39 (-1.91%)	21.25	0.78 (3.81%)	1.32 - 24.97	295,243	622,990	2,883